The Biomedical Research Institute (BRI) is a 501 (c)(3) nonprofit research company committed to improving global health through a variety of research and service activities. For more than 40 years, with the financial support of the NIH, our mission has been to reduce the global health burden imposed by infectious diseases of the developing world, including schistosomiasis, a deadly parasitic disease. Schistosomiasis is responsible for 250,000 deaths annually, while also causing significant morbidity primarily in sub-Saharan Africa, China, the Philippines and parts of South America.

Schistosomiasis Resource Center

Schistosomiasis is a major public health problem in many tropical countries worldwide. After malaria, it is one of the most devastating parasitic diseases. The World Health Organization estimates that 250 million people in 78 countries are infected with schistosomiasis, with more than 800 million at risk of infection annually. In many countries, schistosomiasis ranks near the top in causes of morbidity associated with infectious disease.

Biorepository Services

BRI has close to 70 years of experience in cryobiology. The organization pioneered the cryopreservation of bovine semen and human blood products which is the foundation of modern day in vitro fertilization for agricultural purposes and storage of blood products, respectively. BRI has provided researchers and institutions around the world with low temperature storage space for medical specimens. Our capabilities to store and distribute precious biomaterials help speed research and hasten the discovery of cures and treatments.

Copyright © 2020 Biomedical Research Institute, 9410 Key West Avenue Rockville, MD 20850

Loading...